Category: Approval/Launch Region: Europe · Germany Company: Merckle Gmbh

Mercks Keytruda receives European approval to treat patients with MSI-H or dMMR tumours in five different types of cancer

Mercks Keytruda receives European approval to treat patients with MSI-H or dMMR tumours in five different types of cancer
Merck, known as MSD outside the United States and Canada, announced that the European Commission has approved Keytruda, Merck

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!